iOS app Android app


In Search of a Cure for America's Drug Shortages

Preetam Kaushik | Posted 05.13.2014 | Politics
Preetam Kaushik

Buried under fancy-sounding terms like Trade Related Intellectual Property Rights (TRIPS) and Special 301 is the real irony that availability of cheap drugs is not just a concern for the poor in an India or a China, but also for the poor back home in the US.

FDA Bans More Products From Drugmaker Ranbaxy

Reuters | Posted 03.25.2014 | Healthy Living

* Move to keep "substandard" drugs out of US-FDA * Most Ranbaxy products now barred from key market * Shares in Ranbaxy ...

Suspected Human Hair In Tablet Cited In Import Ban For Indian Drugmaker

Reuters | Posted 11.18.2013 | Healthy Living

By Sumeet Chatterjee Sept 18 (Reuters) - During a visit to a facility of leading Indian drugmaker Ranbaxy Laboratories Ltd last year, ...

An Epic Tale Of Drug-Company Fraud

CNN | Posted 05.17.2013 | Healthy Living

On the morning of Aug. 18, 2004, Dinesh Thakur hurried to a hastily arranged meeting with his boss at the gleaming offices of Ranbaxy Laboratories in ...

India: Wal-Mart's Drug Connection

Al Norman | Posted 05.25.2011 | Business
Al Norman

Most Americans have no idea that the drugs they are buying at Wal-Mart are produced in India, made by companies that are copying another company's products.

Pfizer Delays Generic Lipitor Release Until 2011

Bloomberg | Susan Decker and Shannon Pettypiece | Posted 05.25.2011 | Business

Pfizer Inc. and India's Ranbaxy Laboratories Ltd. agreed to keep copies of the cholesterol pill Lipitor off the U.S. market an extra 20 months, a move...

Pfizer May Get Into Bidding For Ranbaxy, Generic Drug Maker

Reuters | Posted 05.25.2011 | Business

MUMBAI (Reuters) - Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion (2.4 billion pound) offer by Japan's Daiichi Sankyo for the Indi...